Fisher Andrew — SEC Form 4 filings
SEC reporting owner CIK 2014301. 9 Form 4 filings on record with FilingPulse; latest filed 2025-10-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-02 to 2025-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 195,656 shares, $1,967,696 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 80,000 shares @ $11.53 ($922,000) in Verona Pharma plc, filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) | General Counsel | 9 | — | 4 legs · 195,656 sh · $1,967,696 | 26 |
Form 4 filings — Fisher Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-08 | 4 | Verona Pharma plc (VRNA) | Disposition to issuer (D): 417,903 · Option exercise (M): 931,984 · Disposition to issuer (D): 931,984 · Option exercise (M): 146,168 (derivative) · Option exercise (M): 167,056 (derivative) · Grant/award (A): 618,760 (derivative) · +2 more | EDGAR |
| 2025-08-05 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 20,888 @ $0 · Sale (S): 9,584 @ $13.14 · Option exercise (M): 20,888 (derivative) @ $0 | EDGAR |
| 2025-07-09 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 86,064 @ $0 · Tax withholding (F): 39,464 @ $11.44 · Grant/award (A): 253,120 (derivative) @ $0 · Option exercise (M): 86,064 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4/A | Verona Pharma plc (VRNA) | Option exercise (M): 80,000 @ $2.01 · Option exercise (M): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 80,000 @ $2.01 · Sale (S): 80,000 @ $11.53 · Option exercise (M): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 80,000 @ $2.11 · Sale (S): 80,000 @ $8.57 · Option exercise (M): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Verona Pharma plc (VRNA) | Gift (G): 1 @ $0 · Option exercise (M): 86,064 @ $0 · Sale (S): 26,072 @ $8.98 · Grant/award (A): 253,120 (derivative) @ $0 · Option exercise (M): 86,064 (derivative) @ $0 | EDGAR |
| 2024-11-01 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-04-02 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 2,400,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2014301 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →